Skip to main content
webinar register page
The webinar has ended
Register to watch this recording on-demand
Facebook
Twitter
LinkedIn
Microsoft (Outlook)
Topic
Increasing scientific confidence in reliable and relevant approaches for regulatory testing – respiratory toxicity case study
Description
As new approach methodologies (NAMs) are developed, there is a need for robust and efficient processes to establish scientific confidence in these approaches. To gain scientific confidence in NAMs, we can apply a framework that focuses on fitness for purpose, human biological relevance, and technical characterization. Using this framework, several critical differences in physiology, anatomy, and biochemistry between the rat and human respiratory tract become apparent and highlight the value of using human-relevant in vitro models to predict human responses. Because of these differences and the way they limit the ability of the rat to predict human effects, there has been a shift to develop and use human cell-based approaches to characterize potential portal-of-entry effects of inhaled substances. We describe the INSPiRE project, which assessed the value of in vitro models to predict the ability of chemicals to cause portal-of-entry effects on the human respiratory tract. To better understand the impact of experimental design, we assessed four chemicals from two distinct chemical classes in two different cell systems (BEAS-2B cells and MucilAirTM) using various exposure scenarios and biological endpoints. The results give important insights in how in vitro systems can be used to predict effects on the human respiratory tract and inform regulatory decision-making.
Recording Duration
01:20:00
*
Required information
Loading
Register
×
Share via Email
All fields are required
Your Information
Send to
Message preview
Hi there, You are invited to a Zoom webinar. When: Jun 1, 2022 11:00 AM Eastern Time (US and Canada) Topic: Increasing scientific confidence in reliable and relevant approaches for regulatory testing – respiratory toxicity case study Register in advance for this webinar: https://us02web.zoom.us/webinar/register/WN_Lyks2xHOTYSlFOAyaPHxbw After registering, you will receive a confirmation email containing information about joining the webinar.
×
Switch Time Zone
Time Zone:
(GMT-11:00) Midway Island, Samoa
(GMT-11:00) Pago Pago
(GMT-10:00) Hawaii
(GMT-8:00) Alaska
(GMT-8:00) Juneau
(GMT-7:00) Vancouver
(GMT-7:00) Pacific Time (US and Canada)
(GMT-7:00) Tijuana
(GMT-7:00) Arizona
(GMT-7:00) Yukon
(GMT-6:00) Edmonton
(GMT-6:00) Mountain Time (US and Canada)
(GMT-6:00) Mazatlan
(GMT-6:00) Saskatchewan
(GMT-6:00) Guatemala
(GMT-6:00) El Salvador
(GMT-6:00) Managua
(GMT-6:00) Costa Rica
(GMT-6:00) Tegucigalpa
(GMT-6:00) Chihuahua
(GMT-5:00) Winnipeg
(GMT-5:00) Central Time (US and Canada)
(GMT-5:00) Mexico City
(GMT-5:00) Panama
(GMT-5:00) Bogota
(GMT-5:00) Lima
(GMT-5:00) Monterrey
(GMT-5:00) Acre
(GMT-4:00) Montreal
(GMT-4:00) Eastern Time (US and Canada)
(GMT-4:00) Indiana (East)
(GMT-4:00) Puerto Rico
(GMT-4:00) Caracas
(GMT-4:00) Santiago
(GMT-4:00) La Paz
(GMT-4:00) Guyana
(GMT-3:00) Halifax
(GMT-3:00) Montevideo
(GMT-3:00) Recife
(GMT-3:00) Buenos Aires, Georgetown
(GMT-3:00) Sao Paulo
(GMT-3:00) Atlantic Time (Canada)
(GMT-2:30) Newfoundland and Labrador
(GMT-2:00) Greenland
(GMT-2:00) Fernando de Noronha
(GMT-1:00) Cape Verde Islands
(GMT+0:00) Azores
(GMT+0:00) Universal Time UTC
(GMT+0:00) Greenwich Mean Time
(GMT+0:00) Reykjavik
(GMT+0:00) Nouakchott
(GMT+1:00) Dublin
(GMT+1:00) London
(GMT+1:00) Lisbon
(GMT+1:00) Casablanca
(GMT+1:00) West Central Africa
(GMT+1:00) Algiers
(GMT+1:00) Tunis
(GMT+2:00) Belgrade, Bratislava, Ljubljana
(GMT+2:00) Sarajevo, Skopje, Zagreb
(GMT+2:00) Oslo
(GMT+2:00) Copenhagen
(GMT+2:00) Brussels
(GMT+2:00) Amsterdam, Berlin, Rome, Stockholm, Vienna
(GMT+2:00) Amsterdam
(GMT+2:00) Rome
(GMT+2:00) Stockholm
(GMT+2:00) Vienna
(GMT+2:00) Luxembourg
(GMT+2:00) Paris
(GMT+2:00) Zurich
(GMT+2:00) Madrid
(GMT+2:00) Harare, Pretoria
(GMT+2:00) Warsaw
(GMT+2:00) Prague Bratislava
(GMT+2:00) Budapest
(GMT+2:00) Tripoli
(GMT+2:00) Cairo
(GMT+2:00) Johannesburg
(GMT+2:00) Khartoum
(GMT+3:00) Helsinki
(GMT+3:00) Nairobi
(GMT+3:00) Sofia
(GMT+3:00) Istanbul
(GMT+3:00) Athens
(GMT+3:00) Bucharest
(GMT+3:00) Nicosia
(GMT+3:00) Beirut
(GMT+3:00) Damascus
(GMT+3:00) Jerusalem
(GMT+3:00) Amman
(GMT+3:00) Moscow
(GMT+3:00) Baghdad
(GMT+3:00) Kuwait
(GMT+3:00) Riyadh
(GMT+3:00) Bahrain
(GMT+3:00) Qatar
(GMT+3:00) Aden
(GMT+3:00) Djibouti
(GMT+3:00) Mogadishu
(GMT+3:00) Kyiv
(GMT+3:00) Minsk
(GMT+3:00) Chisinau
(GMT+4:00) Dubai
(GMT+4:00) Muscat
(GMT+4:00) Baku, Tbilisi, Yerevan
(GMT+4:30) Tehran
(GMT+4:30) Kabul
(GMT+5:00) Yekaterinburg
(GMT+5:00) Islamabad, Karachi, Tashkent
(GMT+5:30) India
(GMT+5:30) Mumbai, Kolkata, New Delhi
(GMT+5:30) Colombo
(GMT+5:45) Kathmandu
(GMT+6:00) Almaty
(GMT+6:00) Dacca
(GMT+6:00) Astana, Dhaka
(GMT+6:30) Rangoon
(GMT+7:00) Novosibirsk
(GMT+7:00) Krasnoyarsk
(GMT+7:00) Bangkok
(GMT+7:00) Vietnam
(GMT+7:00) Jakarta
(GMT+8:00) Irkutsk, Ulaanbaatar
(GMT+8:00) Beijing, Shanghai
(GMT+8:00) Hong Kong SAR
(GMT+8:00) Taipei
(GMT+8:00) Kuala Lumpur
(GMT+8:00) Singapore
(GMT+8:00) Perth
(GMT+9:00) Yakutsk
(GMT+9:00) Seoul
(GMT+9:00) Osaka, Sapporo, Tokyo
(GMT+9:30) Darwin
(GMT+9:30) Adelaide
(GMT+10:00) Vladivostok
(GMT+10:00) Guam, Port Moresby
(GMT+10:00) Brisbane
(GMT+10:00) Canberra, Melbourne, Sydney
(GMT+10:00) Hobart
(GMT+10:30) Lord Howe IsIand
(GMT+11:00) Magadan
(GMT+11:00) Solomon Islands
(GMT+11:00) New Caledonia
(GMT+12:00) Kamchatka
(GMT+12:00) Fiji Islands, Marshall Islands
(GMT+12:00) Auckland, Wellington
(GMT+13:00) Independent State of Samoa
×
Continue to PayPal
Click to Continue
×
×
Upcoming Meetings
Would you like to start this meeting?
Would you like to start one of these meetings?
View more...